Category: Therapeutics
The Critical Need for Pregnancy Registry Studies and Robust Safety Monitoring in COVID-19 Vaccines
Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.
Time to Act is Now: Paediatrics Medicines Development in the UK
Early Engagement Strategies to Set Cell & Gene Therapies Up for Success
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
RACE Act: A Promising Catalyst for Improved Pediatric Cancer Treatments
Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
Mitigating Impacts of a Global Pandemic in the Clinical Development Space
UK Achieves Site Activation World Record for Roche During COVID-19 Pandemic